← FDA Drug Approvals (Drugs@FDA)

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2025-07-25

Drug application

FDA Application #

ANDA209199

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Generic name

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Active ingredients

HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD V

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2025-07-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown